(1)
THE SIGNIFICANCE OF CLINICAL-LABORATORY AND MOLECULAR-GENETIC MARKERS IN THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE. Nova. Pub. 2025, No. 30, 1-134.